A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model. - Su EJ; Tsou PS; Warnock M; Subbotina N; Mann K; Vichaikul S; Rosek A; Leung L; Xing X; Xing E; Plazyo O; Bogle R; et al. (JCI insight, 2026)